These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9287458)

  • 1. Meningococcal disease in Australia; looking at the past, thinking of the future.
    Patel M
    Commun Dis Intell; 1997 Aug; 21(17):233-6. PubMed ID: 9287458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern].
    de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease--management of serogroup C clusters in a hyperendemic area.
    Dell E; Bedford D; McMahon B; Nicholson A
    Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
    Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
    Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microevolution during epidemic spread of Neisseria meningitidis.
    Achtman M
    Electrophoresis; 1998 Apr; 19(4):593-6. PubMed ID: 9588808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular epidemiology of invasive meningococcal disease in the Czech Republic].
    Krízová P; Kalmusová J; Musílek M
    Epidemiol Mikrobiol Imunol; 2006 Nov; 55(4):140-50. PubMed ID: 17354589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].
    Renevey F; Demierre G; Chuard C; Regamey C
    Rev Med Suisse Romande; 2001 Aug; 121(8):569-72. PubMed ID: 11565217
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.